Background Parenchymal Enhancement at Breast MR Imaging and Breast Cancer Risk

被引:281
|
作者
King, Valencia [1 ]
Brooks, Jennifer D. [2 ]
Bernstein, Jonine L. [2 ]
Reiner, Anne S. [2 ]
Pike, Malcolm C. [2 ]
Morris, Elizabeth A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Evelyn H Lauder Breast Ctr, New York, NY 10065 USA
关键词
HORMONE REPLACEMENT THERAPY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC FEATURES; MENSTRUAL-CYCLE; TISSUE; DENSITY; WOMEN; PATTERNS; CLASSIFICATION; AGE;
D O I
10.1148/radiol.11102156
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the relationships between breast cancer and both amount of fibroglandular tissue (FGT) and level of background parenchymal enhancement (BPE) at magnetic resonance (MR) imaging. Materials and Methods: A waiver of authorization was granted by the institutional review board for this retrospective HIPAA-compliant study. Among 1275 women who underwent breast MR imaging screening between December 2002 and February 2008, 39 breast carcinoma cases were identified. Two comparisons were performed: In one comparison, two normal controls-those of the women with negative (benign) findings at breast MR imaging-were matched to each breast cancer case on the basis of age and date of MR imaging. In the second comparison, one false-positive control-that of a woman with suspicious but nonmalignant findings at MR imaging-was similarly matched to each breast cancer case. Two readers independently rated the level of MR imaging-depicted BPE and the amount of MR imaging-depicted FGT by using a categorical scale: BPE was categorized as minimal, mild, moderate, or marked, and FGT was categorized as fatty, scattered, heterogeneously dense, or dense. Results: Compared with the odds ratio (OR) for a normal control, the OR for breast cancer increased significantly with increasing BPE: The ORs for moderate or marked BPE versus minimal or mild BPE were 10.1 (95% confidence interval [CI]: 2.9, 35.3; P < .001) and 3.3 (95% CI: 1.3, 8.3; P = .006) for readers 1 and 2, respectively. Similar odds were seen when the false-positive controls were compared with the breast cancer cases: The ORs for moderate or marked BPE versus minimal or mild BPE were 5.1 (95% CI: 1.4, 19.1; P = .005) and 3.7 (95% CI: 1.2, 11.2; P = .013) for readers 1 and 2, respectively. The breast cancer odds also increased with increasing FGT, but the BPE findings remained significant after adjustment for FGT. Conclusion: Increased BPE is strongly predictive of breast cancer odds. (C) RSNA, 2011
引用
收藏
页码:50 / 60
页数:11
相关论文
共 50 条
  • [41] Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
    Hruska, Carrie B.
    Geske, Jennifer R.
    Swanson, Tiffinee N.
    Mammel, Alyssa N.
    Lake, David S.
    Manduca, Armando
    Conners, Amy Lynn
    Whaley, Dana H.
    Scott, Christopher G.
    Carter, Rickey E.
    Rhodes, Deborah J.
    O'Connor, Michael K.
    Vachon, Celine M.
    BREAST CANCER RESEARCH, 2018, 20
  • [42] Background parenchymal enhancement in preoperative breast MRI
    Kohara, Satoko
    Ishigaki, Satoko
    Satake, Hiroko
    Kawamura, Akiko
    Kawai, Hisashi
    Kikumori, Toyone
    Naganawa, Shinji
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2015, 77 (03): : 373 - 382
  • [43] The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
    Hellgren, Roxanna
    Saracco, Ariel
    Strand, Fredrik
    Eriksson, Mikael
    Sundbom, Ann
    Hall, Per
    Dickman, Paul W.
    ACTA RADIOLOGICA, 2020, 61 (12) : 1600 - 1607
  • [44] Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI
    Yan, Ran
    Murakami, Wakana
    Mortazavi, Shabnam
    Yu, Tiffany
    Chu, Fang-I.
    Lee-Felker, Stephanie
    Sung, Kyunghyun
    EUROPEAN RADIOLOGY, 2024, 34 (10) : 6358 - 6368
  • [45] Racial differences in background parenchymal enhancement, a novel marker of breast cancer
    Mahmoud, Mattia
    Ehsan, Sarah
    Mack, Elizabeth
    Edmonds, Christine E.
    Kontos, Despina
    Chen, Jinbo
    Fayanju, Oluwadamilola Motunrayo
    McCarthy, Anne Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Background parenchymal enhancement in breast MRIs of breast cancer patients: Impact on tumor size estimation
    Baek, Ji Eun
    Kim, Sung Hun
    Lee, Ah Won
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (08) : 1356 - 1362
  • [47] Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk
    Grimm, Lars J.
    Saha, Ashirbani
    Ghate, Sujata V.
    Kim, Connie
    Soo, Mary Scott
    Yoon, Sora C.
    Mazurowski, Maciej A.
    ACADEMIC RADIOLOGY, 2019, 26 (01) : 69 - 75
  • [48] Breast density, MR imaging biomarkers, and breast cancer risk
    Porembka, Jessica H.
    Ma, Jingfei
    Le-Petross, Huong T.
    BREAST JOURNAL, 2020, 26 (08): : 1535 - 1542
  • [49] \ MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
    Amano, Yasuo
    Woo, Jun
    Amano, Maki
    Yanagisawa, Fumi
    Yamamoto, Hiroshi
    Tani, Mayumi
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [50] Background Parenchymal Enhancement at Breast MRI: More Is Not Better
    Niell, Bethany L.
    RADIOLOGY, 2023, 306 (01) : 100 - 101